Activation of NK cell (human and mouse) by immunostimulatory DNA sequence.
Yamamoto
S
S
Department of Bacterial and Blood Products, National Institute of Infectious Diseases, Tokyo, Japan.
Yamamoto
T
T
Iho
S
S
Tokunaga
T
T
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D001483:Base Sequence; D002478:Cells, Cultured; D018899:CpG Islands; D004269:DNA, Bacterial / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D006801:Humans; D007271:Injections, Intradermal; D007274:Injections, Intraperitoneal; D007372:Interferons / Q000096:biosynthesis; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology; D008081:Liposomes; D008213:Lymphocyte Activation / Q000187:drug effects*; D051379:Mice; D008807:Mice, Inbred BALB C; D009163:Mycobacterium bovis / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D009360:Neoplastic Cells, Circulating; D009838:Oligodeoxyribonucleotides / Q000138:chemical synthesis / Q000276:immunology / Q000494:pharmacology; D010529:Peritoneal Cavity / Q000166:cytology; D011068:Poly G / Q000276:immunology; D013154:Spleen / Q000166:cytology / Q000276:immunology
D000276:Adjuvants, Immunologic; D004269:DNA, Bacterial; D008081:Liposomes; D009838:Oligodeoxyribonucleotides; D011068:Poly G; C026628:poly(dG); D007372:Interferons